NEW YORK, March 5 – With $150 million in capital commitments, Applied Genomic Technology Capital Funds has closed its first venture funds, the Cambridge, Mass., venture capital group said Monday.

AGTC Funds, which was founded by venture capital firms NewcoGen and OneLiberty Ventures, plans to finance early-stage genomics companies that focus on information, discoveries, and technology. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.